Globulin

Group of proteins including antibodies

18/22Providers

Liver FunctionCategory

liver diseaseReference

Widely Available

18 of 22 providers

Reference Range

liver disease

What is Globulin?

Globulins are a diverse group of proteins in your blood that serve multiple vital functions, primarily related to immune system function and substance transport. They account for about 40-45% of total plasma protein. Globulins are typically calculated as Total Protein minus Albumin, though they can also be measured by serum protein electrophoresis (SPEP) which separates them into subfractions.

Globulins consist of several types:alpha-1 and alpha-2 globulins (transport proteins and acute phase reactants), beta globulins (including transferrin for iron transport and complement proteins for immunity), and gamma globulins (immunoglobulins or antibodies produced by plasma cells). The albumin/globulin (A/G) ratio is clinically useful—a low ratio suggests immune activation, chronic infection, or liver disease.

Elevated globulins typically indicate immune system activation from chronic infections, autoimmune diseases, or production of abnormal proteins (like in multiple myeloma). Low globulins suggest immune deficiency or protein loss. Unlike albumin which reflects liver synthesis and nutrition, globulins primarily reflect immune system activity and inflammatory status.

Why Globulin Reveals Your Immune and Inflammatory Status

Immune function indicator:Gamma globulins (antibodies) reflect immune system capacity. Low levels indicate immunodeficiency;high levels suggest chronic infection or autoimmune disease
Chronic disease detection:Elevated globulins are seen in chronic infections (TB, HIV, hepatitis), autoimmune conditions (lupus, RA), and malignancies (multiple myeloma, lymphoma)
A/G ratio significance:Low A/G ratio (<1.0) suggests chronic inflammation, liver disease, or protein-losing conditions. High ratio (>2.5) may indicate immunodeficiency
Monoclonal protein screening:Markedly elevated globulins (>5 g/dL) warrant investigation for multiple myeloma or other plasma cell disorders
Inflammation marker:Globulins increase as acute-phase reactants during inflammation, complementing CRP and ESR
Protein loss detection:Low globulins with low albumin indicate protein-losing enteropathy or nephrotic syndrome

Optimal vs Standard Ranges

Range Type	Level	Significance
Optimal	2.0-3.5 g/dL	Normal immune function with balanced inflammatory status. A/G ratio of 1.2-2.2 is optimal, indicating appropriate balance between liver protein synthesis (albumin) and immune proteins (globulins). Reflects absence of chronic infection, autoimmune disease, or significant inflammation.
Borderline High	3.5-4.5 g/dL	Suggests mild immune activation or chronic inflammation. Common in chronic infections, mild autoimmune conditions, or chronic inflammatory states. Check A/G ratio—if <1.0, investigate further. Consider CRP, ESR, and SPEP. If isolated finding without symptoms, may reflect individual variation. Retest in 3-6 months.
Low (Hypoglobulinemia)	<2.0 g/dL	Indicates immunodeficiency, protein loss, or liver synthesis dysfunction. Check immunoglobulin levels (IgG, IgA, IgM) to assess immune function. Evaluate for primary immunodeficiency (genetic), secondary immunodeficiency (HIV, medications), protein-losing enteropathy, or nephrotic syndrome. If low albumin also present, suggests severe protein loss or malnutrition.
High (Hyperglobulinemia)	>4.5 g/dL	Indicates significant immune activation or pathological protein production. A/G ratio typically <1.0. Requires investigation with SPEP to differentiate polyclonal (multiple types) from monoclonal (single type) elevation. Polyclonal:Chronic infections (hepatitis, TB, HIV), autoimmune diseases (lupus, RA, Sjögren's), chronic liver disease. Monoclonal (>5 g/dL):Multiple myeloma, lymphoma, chronic lymphocytic leukemia. Urgent hematology referral if monoclonal spike present.

Standard lab range: liver disease

How to Optimize Globulin

1. Address Chronic Infections (if High Globulins)

Screen for chronic infections:Hepatitis B/C serology, HIV testing, tuberculosis (QuantiFERON or PPD), fungal infections if immunocompromised

Treat active infections:Antiviral therapy for hepatitis or HIV, antibiotics for chronic bacterial infections, antifungals if indicated

Support immune clearance:Adequate vitamin D (40-60 ng/mL), zinc (15-30 mg daily), vitamin C (500-1000 mg daily)

Probiotics:10-50 billion CFU daily may support immune function and reduce pathogenic bacteria

Monitor treatment response:Retest globulins after treating underlying infection;should normalize within 3-6 months

2. Manage Autoimmune and Inflammatory Conditions

Autoimmune disease treatment:Follow specialist guidance for lupus, rheumatoid arthritis, Sjögren's syndrome, inflammatory bowel disease

Anti-inflammatory diet:Mediterranean diet, omega-3 fatty acids (2-4g EPA+DHA daily), minimize processed foods

Immunomodulatory supplements:Vitamin D (2000-5000 IU daily), omega-3s, curcumin (500-1000 mg daily), resveratrol

Stress management:Chronic stress worsens autoimmune conditions. Practice meditation, adequate sleep (7-9 hours)

Regular monitoring:Check globulins and A/G ratio every 3-6 months to assess disease activity

3. Investigate and Treat Monoclonal Gammopathy (if Very High)

SPEP and immunofixation:Required if globulin >4.5 g/dL or A/G ratio <0.8 to detect monoclonal protein

MGUS vs Myeloma:Monoclonal protein <3 g/dL with normal calcium/kidney function suggests MGUS (benign but requires monitoring). Higher levels or organ damage suggest myeloma

Hematology referral:Urgent if monoclonal spike present. May require bone marrow biopsy, skeletal survey, free light chains

Monitor MGUS:If benign monoclonal gammopathy, monitor every 6-12 months (1% annual risk of progression to myeloma)

Treatment for myeloma:Chemotherapy, immunotherapy, or stem cell transplant if diagnosed with multiple myeloma

4. Support Immune Function (if Low Globulins)

Immunoglobulin replacement:If severe immunodeficiency (<400 mg/dL IgG), may require IVIG (intravenous immunoglobulin) or SCIG (subcutaneous) therapy

Optimize nutrition:Adequate protein (1.0-1.2 g/kg), zinc (15-30 mg daily), vitamin A (5000-10000 IU daily), vitamin E (400 IU daily)

Avoid immunosuppressive medications:Review medications with doctor;corticosteroids and chemotherapy suppress globulin production

Vaccination:Ensure up-to-date on vaccines, though response may be impaired. Consider pneumococcal, flu, COVID-19 vaccines

Infection prevention:If immunodeficient, practice strict hand hygiene, avoid sick contacts, consider prophylactic antibiotics

5. Address Protein Loss (if Low Globulin + Low Albumin)

Investigate protein loss:Check 24-hour urine protein (nephrotic syndrome causes >3g/day loss). Stool alpha-1 antitrypsin if GI protein loss suspected

Treat nephrotic syndrome:ACE inhibitors/ARBs reduce proteinuria. Immunosuppression if underlying glomerular disease

Manage protein-losing enteropathy:Treat inflammatory bowel disease, celiac disease, or intestinal lymphangiectasia

Increase protein intake:1.2-1.8 g/kg body weight daily to compensate for losses

Monitor response:Retest total protein, albumin, globulin every 4-8 weeks during treatment

Symptoms of Abnormal Globulin

Low Globulin

Recurrent infections:Frequent respiratory infections, sinusitis, ear infections, pneumonia (if immunodeficiency)
Poor wound healing:Slow recovery from injuries or surgeries
Chronic fatigue:Due to underlying infection or immune dysfunction
Swelling:If associated with low albumin and protein loss (nephrotic syndrome, protein-losing enteropathy)

High Globulin

Often asymptomatic:Mild to moderate elevations (3.5-4.5 g/dL) typically cause no symptoms
Symptoms of underlying condition:Fatigue, fever, night sweats (infections or lymphoma), joint pain and rash (autoimmune diseases), bone pain (multiple myeloma)
Hyperviscosity syndrome:If extreme elevation (>8-10 g/dL), blood becomes thick causing headaches, vision changes, bleeding, confusion (medical emergency)
Signs of multiple myeloma:Bone pain (especially back), recurrent infections, fatigue, kidney dysfunction, hypercalcemia

Causes of Abnormal Globulin

Low Levels

Primary immunodeficiency:Genetic conditions causing low immunoglobulin production (common variable immunodeficiency, X-linked agammaglobulinemia)
Secondary immunodeficiency:HIV/AIDS, medications (corticosteroids, chemotherapy, immunosuppressants), chronic lymphocytic leukemia
Protein loss:Nephrotic syndrome (massive urinary protein loss), protein-losing enteropathy (GI loss from IBD, celiac, lymphangiectasia)
Severe malnutrition:Inadequate protein intake or malabsorption
Liver disease:Severe cirrhosis reduces globulin synthesis (though often high due to immune activation)
Burns or major trauma:Protein loss from wounds

High Levels

Chronic infections:Hepatitis B/C, HIV, tuberculosis, chronic osteomyelitis, subacute bacterial endocarditis, fungal infections
Autoimmune diseases:Systemic lupus erythematosus (SLE), rheumatoid arthritis, Sjögren's syndrome, autoimmune hepatitis, sarcoidosis
Chronic liver disease:Cirrhosis causes polyclonal hyperglobulinemia (chronic immune stimulation from gut bacteria)
Inflammatory conditions:Inflammatory bowel disease (Crohn's, ulcerative colitis), chronic pancreatitis
Malignancies:Multiple myeloma (monoclonal spike), Waldenstrom macroglobulinemia, lymphoma, chronic lymphocytic leukemia
Monoclonal gammopathy of undetermined significance (MGUS):Benign but requires monitoring for progression
Amyloidosis:Abnormal protein deposition disease

When to Retest

If borderline high (3.5-4.5 g/dL) and asymptomatic:Retest in 3-6 months with A/G ratio, CRP, ESR. If stable and no symptoms, likely individual variation
If high (>4.5 g/dL):Retest within 4-8 weeks with SPEP to differentiate polyclonal vs monoclonal elevation. Check inflammatory markers (CRP, ESR) and screen for infections/autoimmune diseases
If monoclonal spike detected:Urgent hematology referral. Repeat SPEP with immunofixation, free light chains, bone marrow biopsy. Monitor MGUS every 6-12 months
If low (<2.0 g/dL):Check immunoglobulin subfractions (IgG, IgA, IgM) within 2-4 weeks. If IgG <400 mg/dL, refer to immunology. Investigate protein loss (urine protein, stool alpha-1 antitrypsin)
During treatment:Monitor every 3-6 months in chronic infections, autoimmune disease, or MGUS. Globulins should decrease with successful treatment of inflammation/infection

Scientific Evidence

Albumin/Globulin Ratio in Liver Disease

In chronic liver disease, the A/G ratio progressively decreases as cirrhosis advances. Albumin synthesis declines while globulins increase due to chronic immune activation. A/G ratio <1.0 is commonly seen in cirrhosis and correlates with disease severity. The ratio helps distinguish cirrhosis from other causes of low albumin.

Source:Busher JT. Serum Albumin and Globulin. In:Walker HK, et al., editors. Clinical Methods:The History, Physical, and Laboratory Examinations. 3rd edition. 1990.

Hyperglobulinemia as Clue to Multiple Myeloma

Multiple myeloma typically presents with markedly elevated globulins (>5 g/dL) and A/G ratio <1.0 due to monoclonal immunoglobulin production by malignant plasma cells. SPEP reveals a characteristic monoclonal spike. Early detection through recognition of elevated globulins and appropriate workup improves outcomes, as treatment is most effective when started before significant organ damage.

Source:Kyle RA, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356(25):2582-2590.

MGUS Prevalence and Progression

Monoclonal gammopathy of undetermined significance (MGUS) affects 3-5% of people over age 50 and ~8% over age 70. Most cases are benign, but MGUS progresses to multiple myeloma at a rate of ~1% per year. Monitoring includes serial SPEP, free light chains, and clinical assessment. Higher risk features include elevated free light chain ratio and monoclonal protein >1.5 g/dL.

Source:Kyle RA, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354(13):1362-1369.

Hypoglobulinemia and Infection Risk

Patients with IgG <400 mg/dL have significantly increased risk of recurrent bacterial infections, particularly encapsulated organisms (pneumococcus, H. influenzae). Immunoglobulin replacement therapy (IVIG or SCIG) reduces infection rates by 60-80% in patients with primary or secondary immunodeficiency causing hypoglobulinemia.

Source:Bonilla FA, et al. Practice parameter for the diagnosis and management of primary immunodeficiency. J Allergy Clin Immunol. 2015;136(5):1186-1205.

Globulins in Autoimmune Disease

Polyclonal hyperglobulinemia is common in autoimmune diseases, reflecting widespread B-cell activation and antibody production. In SLE, elevated globulins (3.5-5.5 g/dL) with low A/G ratio (<1.0) are typical. Globulin levels correlate with disease activity—decreasing with successful treatment and increasing during flares. Serial monitoring aids in disease management.

Source:Arbuckle MR, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349(16):1526-1533.

Provider	Includes	Annual Cost	Biomarkers
Superpower	✓	$199	100+ (150 with ratios)
WHOOP Advanced Labs	✓	$349	65
Labcorp OnDemand	—	$398	30+
Life Extension	✓	$486	40+
Everlywell	—	$468	83
Mito Health	✓	$349	100+
InsideTracker	—	$680	54
Function Health	✓	$365	100+
Marek Health Base	✓	$250	65
Marek Health Comprehensive	✓	$495	70+
Marek Health Complete	✓	$895	100+
Marek Health Executive	✓	$1950	150+
Blueprint	—	$399	100+
Quest Health	—	$Varies	75+
Empirical Health	✓	$190	100+
Oura Health Panels	✓	$99	50
SiPhox Health	✓	$125	60
Hims Labs Base	✓	$199	50
Hims Labs Advanced	✓	$499	120+
Healthspan	✓	$4188	80+
Vitality Blueprint Standard	✓	$375	85
Vitality Blueprint Elite	✓	$700	129